Peng Lun

Peng Lun

Auto-generated profile, based on publicly available information

Peng Lun

Department of Neurosurgery, the Affiliated Hospital of Qingdao University, Qingdao, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
XCXiaodong Chen
Xiaodong Chen
FTFen Tian
Fen Tian
PLPeng Lun
Peng Lun
YFYugong Feng
Yugong Feng
Meningiomas, which are the most common primary intracranial tumors, have highly aggressive cells in malignant cases. Due to its extensive antitumor effects, curcumin is widely used in experimental and clinical studies. However, the role of curcumin during the epithelial-mesenchymal transition (EMT) in meningioma has not been established. We found that curcumin blocks hepatocyte growth factor- (HGF-) induced proliferation, migration, invasion, and EMT of human malignant meningioma cells by regulating the PI3K/Akt/mTOR signaling pathway. In addition, treatment of human malignant meningioma cells with the tyrosine protein kinase (c-MET) inhibitor (SU11274) or the phosphoinositide 3-kinase (PI3K) inhibitor (LY294002) suppressed HGF-induced migration and EMT. Furthermore, we found that curcumin inhibited tumor growth and HGF-induced EMT in mice subjected to subcutaneous xenotransplantation. These findings indicate that HGF regulates EMT in human malignant meningioma cells through c-MET/PI3K/Akt/mTOR modulation. In conclusion, curcumin inhibits HGF-induced EMT by targeting c-MET and subsequently blocking the PI3K/Akt/mTOR pathway.

9 October 2023 in Frontiers in Neuroscience
Verified
Journal Article
Open access
FWFuxu Wang
Fuxu Wang
AMAnbang Ma
Anbang Ma
ZWZeyu Wu
Zeyu Wu
MXMingchen Xie
Mingchen Xie
PLPeng Lun
Peng Lun
PSPeng Sun
Peng Sun
The study aims to develop a magnetic resonance imaging (MRI)-based radiomics model for the diagnosis of classic trigeminal neuralgia (cTN). This study involved 350 patients with cTN and 100 control participants. MRI data were collected retrospectively for all the enrolled subjects. The symptomatic side trigeminal nerve regions of patients and both sides of the trigeminal nerve regions of control participants were manually labeled on MRI images. Radiomics features of the areas labeled were extracted. Principle component analysis (PCA) and least absolute shrinkage and selection operator (LASSO) regression were utilized as the preliminary feature reduction methods to decrease the high dimensionality of radiomics features. Machine learning methods were established, including LASSO logistic regression, support vector machine (SVM), and Adaboost methods, evaluating each model’s diagnostic abilities using 10-fold cross-validation. All the models showed excellent diagnostic ability in predicting trigeminal neuralgia. A prospective study was conducted, 20 cTN patients and 20 control subjects were enrolled to validate the clinical utility of all models. Results showed that the radiomics models based on MRI can predict trigeminal neuralgia with high accuracy, which could be used as a diagnostic tool for this disorder.

25 September 2026 in Journal of King Saud University Computer and Information Sciences
Verified
Journal Article
Open access
PDF file
MXMing-chen Xie
Ming-chen Xie
XLXueyan Li
Xueyan Li
XLXia Liu
Xia Liu
XCXiaodong Chen
Xiaodong Chen
PLPeng Lun
Peng Lun
Reliable computer-aided analysis of brain-tumor MRI must be accurate, robust to the imaging conditions encountered in practice, and interpretable in a form that can be documented and reviewed. We present CMDA-Net, a framework built around two contributions. The first, which we validate experimentally, is an auditable classification pipeline: a 2D residual–CBAM classifier (CMDA-Cls) coupled with a SHAP-based interpretation layer that goes beyond heatmaps to emit a centre-versus-periphery separability metric and an attribution-weighted confusion matrix, archived in a versionable multi-sheet report to support post-hoc auditing. On the four-class Brain Tumor MRI benchmark, CMDA-Cls attains \(99.47\%\) accuracy and \(99.44\%\) macro-F1 on the full held-out test set (\(N{=}1311\)), with \(97.09\%\!\pm \!0.55\%\) accuracy under stratified 5-fold cross-validation, and the centre-to-periphery attribution ratio exceeds one for every class (from 1.17 on pituitary to 2.94 on meningioma), excluding peripheral-shortcut behaviour. The second contribution is architectural: a 3D multi-modal segmentation network (CMDA-Seg) that couples Cross-Modal Attention Fusion (CMAF), a survival-constrained Modality-Dropout (MoDrop) regularizer and a FiLM-conditioned decoder to fuse MRI modalities adaptively and to degrade gracefully when modalities are missing. Because a multi-parametric segmentation cohort was not available for this study, CMDA-Seg is presented as a design contribution whose four-modality evaluation is left to future work.

22 September 2026 in Journal of King Saud University Computer and Information Sciences
Verified
Journal Article
Open access
PDF file
XLXueyan Li
Xueyan Li
MXMing-chen Xie
Ming-chen Xie
XLXia Liu
Xia Liu
XCXiaodong Chen
Xiaodong Chen
PLPeng Lun
Peng Lun
Heterogeneous multi-modal data that mixes categorical demographics, continuous biomarkers and high-dimensional binary indicators remains a long-standing challenge for deep learning, particularly when fusion across modalities is delegated to undifferentiated attention blocks and when the resulting predictor must be deployed under strict interpretability constraints. We propose a multi-modal mixture-of-experts deep network that injects modality-specific inductive bias into the fusion pipeline rather than treating heterogeneous streams as exchangeable token sequences. The model couples three dedicated encoders—a clinical encoder equipped with a learnable periodic embedding for the continuous variables, a dynamics encoder that re-orders binary indicators along a pseudo-temporal axis and processes them with stacked dilated temporal convolutions modulated by Feature-wise Linear Modulation, and a structural encoder that combines three Graph Attention layers with a Transformer block over a soft fully-connected graph—and integrates them through pairwise cross-pathway attention, gated fusion and a Top-2-of-6 Mixture-of-Experts router. The whole pipeline is trained end-to-end under a multi-task objective that jointly couples classification, evidential uncertainty estimation, auxiliary multi-label prediction and risk regression. To make the resulting predictor inspectable, we further design a four-layer Tree-SHAP attribution framework that operates on a distilled tree-based surrogate—trained to reproduce the deep model’s outputs rather than the raw label—and exposes the model at the global, sample, interaction and subgroup levels within a single coherent pipeline. On a programmatically simulated heterogeneous cohort of 420 cases spanning 21 multi-modal variables, the end-to-end network attains an AUC of \(0.994\pm 0.014\) and an accuracy of \(98.8\pm 1.2\,\%\) under \(5\times 5\) repeated stratified cross-validation; an extensive analysis shows that this cohort is near-linearly separable (so conventional baselines saturate as well), that performance degrades gracefully under simulated acquisition shift and reduced class separation, that a label-permutation control collapses to chance, and that the distilled surrogate reproduces the deep predictor (probability \(R^{2}{=}0.77\), class agreement \(94\,\%\)), which makes the subsequent attribution layer faithful by construction. The hierarchical attribution analysis further shows that eight features account for over \(80\,\%\) of the predictive signal, cross-modality interactions contribute \(55.6\,\%\) of the top-50 interaction strength, and the per-subgroup evidence chains remain strictly symmetric around the population expectation. Together, these results—reported with their limitations made explicit—establish PD-GliomaNet and its hierarchical Tree-SHAP companion as a transferable blueprint for accurate, uncertainty-aware and inspectable multi-modal deep learning on heterogeneous data.

27 March 2026 in IEEE Transactions on Neural Networks and Learning Systems
Verified
Journal Article
Closed access
XLXiang Lu
Xiang Lu
XDXuexin Du
Xuexin Du
PLPeng Lun
Peng Lun
YRYande Ren
Yande Ren
In deep brain stimulation (DBS) surgery for Parkinson’s disease (PD), the accurate intraoperative identification of key nuclei—such as the subthalamic nucleus (STN)—is critical to ensuring therapeutic efficacy. However, current approaches heavily depend on expert annotations, and classification tasks are typically confined to binary distinctions between STN and non-STN regions. This limitation hampers the real-time recognition of complex and diverse neuroanatomical structures during PD-related DBS procedures. To overcome this challenge, we propose a three-class classification strategy for microelectrode recording (MER) signals to effectively distinguish the zona incerta (Zi), STN, and substantia nigra (SN). This approach integrates supervised feature selection with unsupervised clustering: discriminative features are first selected using the random forest algorithm; these features are then input into fuzzy c-means (FCM) clustering for preliminary classification; finally, samples with low-confidence scores are manually reviewed. This strategy forms an efficient and verifiable label-generation mechanism that improves classification accuracy and enhances clinical applicability. Experimental results show that the proposed ”clustering + review” labeling framework achieves an overall classification accuracy of 92.71%, with only about 10% of samples requiring manual verification—closely matching the 92.97% accuracy achieved with expert labeling and significantly improving labeling efficiency. Furthermore, the ROC-AUC values for all three nuclei (Zi, STN, and SN) exceed 0.97, confirming the model’s robust discriminative performance. By combining supervised and unsupervised techniques, the proposed multinuclei classification framework for MER signals not only ensures high accuracy while substantially reducing manual annotation costs but also offers a scalable and efficient solution for rapid neural signal labeling. This method is particularly well-suited for real-time applications such as intraoperative target localization during DBS and shows strong potential for clinical translation.

1 January 2026 in Human Mutation
Verified
Journal Article
Open access
PDF file
MLMengtong Li
Mengtong Li
JLJiayi Liu
Jiayi Liu
ZLZichen Liu
Zichen Liu
XLXia Liu
Xia Liu
PLPeng Lun
Peng Lun
Glioblastoma (GBM) remains a lethal brain tumor with limited prognostic tools. Metabolic reprogramming, particularly in understudied pathways like propionate metabolism, may offer new biomarkers. Here, we identified a novel prognostic signature based on seven propionate metabolism‐related genes (SLC9A1, ELANE, ACADS, SOAT2, MYD88, ADSL, and BMP2) from the TCGA‐GBM cohort. A risk scoring model was constructed via LASSO Cox regression effectively stratified patients into high‐ and low‐risk groups with significant survival differences, which was also validated in independent GEO datasets. Multiomics analysis revealed that the high‐risk group was associated with an immunosuppressive microenvironment, characterized by increased immune checkpoint expression and distinct immune cell infiltration. Mutational profiling showed a strong association with key driver alterations, including enrichment of RB1 mutations in high‐risk and IDH1 mutations in low‐risk patients. Single‐cell RNA‐seq (scRNA‐seq) analysis confirmed the specific enrichment of signature genes within malignant cells, and coexpression network analysis (hdWGCNA) further linked the high‐risk phenotype to transcriptional modules. In conclusion, we established and validated a robust metabolic gene signature that not only predicts prognosis but also delineates a high‐risk GBM subtype defined by integrated metabolic, immunogenomic, and transcriptional features, providing new insights into the determinants of GBM aggressiveness.